Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Cell|July 21, 2021
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cellsDong Chen, Siyuan Xia, Rukang Zhang, et al.
Cancer Discovery|March 14, 2019
Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in CancerDong Chen, Siyuan Xia, Mei Wang, et al.
Journal for Immunotherapy of Cancer|May 3, 2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphomaSharmila Raghunandan, Melinda Pauly, William G Blum, et al.
JAMA Network Open|June 23, 2025
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaRichard J Marrero, Vivek M Shastri, Deedra Nicolet, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid LeukemiaDarren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Leukemia|June 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemiaDarren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Haematologica|November 6, 2025
IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapyFieke W Hoff, Ying Huang, Rina Li Welkie, et al.
Leukemia|November 28, 2023
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Blood Advances|October 23, 2023
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AMLSheng F Cai, Ying Huang, Jennie R Lance, et al.
Pageof 3